In This Section

Developmental Neurotoxicity of Cannabinoids

Tuesday April 05, 2022

8:00 am - 9:30 am Eastern Time (ET)



BEH DMDD MP NEU TOX TCP

Chair :

Qingcheng Mao
Univ of Washington School of Pharmacy

Qing Ma
University at Buffalo



Recent studies have revealed that cannabis is the second most used drug after alcohol in the US. Evidence shows that cannabis use in adolescents and young adults is associated with adverse neurocognitive reactions. Studies also show that cannabis use by pregnant women has been consistently increasing over time. Cannabis use among these special populations is expected to further increase with recent trends toward legalization of recreational consumption, representing a potential but great public health concern. This symposium is therefore timely with respect to understanding neurotoxicity of cannabinoids in infants and adolescents.

Speakers

Ken Mackie - Indiana University

Enduring Molecular, Physiological, and BehavioralEeffects of Perinatal Cannabinoids: Mechanisms and Possible Therapeutic Strategies for their Treatment

Dr. Mackie is an expert in the area of cannabinoid receptors and their roles in the psychoactive and therapeutic actions of cannabis. He will present his recent work on physiological and behavioral effects of perinatal cannabinoids including THC and CBD in animal models.

Ryan Bogdan - Washington University in St. Louis

Associations Between Prenatal Cannabis Exposure and Psychopathological and Neurological Childhood Outcomes

Dr. Bogdan is an expert in understanding how early life adversity and later stress exposure shape risk for mental and physical health outcomes. He will present his recent data on associations between prenatal cannabis use and adverse psychopathological and neurological childhood outcomes

Jennifer Iudicello - University of California San Diego.

Cannabis Use, Inflammation, and the Brain

Dr. Iudicello is an expert in neuropsychology and biomarker research among vulnerable populations, particularly people with HIV. She will present her recent work on the effects of cannabis on the central nervous system and downstream effects on behavior.

Talks will be selected from submitted abstracts.

Last Updated: August 31, 2021
Key Dates
 
November 30, 2021

Abstract Submission Deadline

February 7, 2022

Early Registration Deadline

April 2 – 5, 2022

ASPET Annual Meeting at EB 2022

Thank you to our Annual Meeting partners:

jpet_banner
molpharm_banner
dmd_banner
pharmrev_banner